| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 26,527 |
| Depreciation and amortization | 12,830 |
| Amortization of debt issuance costs | 572 |
| Deferred income taxes | 2,171 |
| Foreign currency gains, net | 239 |
| Acquisition-related items | 1,117 |
| Stock-based compensation expense | 339 |
| Other | 474 |
| Accounts receivable, net | -11,366 |
| Inventories, net | 26,181 |
| Other current assets | 306 |
| Other assets | 105 |
| Accounts payable | -4,627 |
| Accrued expenses and other liabilities | -13,688 |
| Net cash provided by operating activities | 9,302 |
| Purchases of short-term investments | 12,504 |
| Maturities of short-term investments | 9,000 |
| Capital expenditures | 13,806 |
| Other, net | 3,704 |
| Net cash used by investing activities | -21,014 |
| Revolving credit facility borrowings | 86,000 |
| Revolving credit facility repayments | 58,000 |
| Payments of long-term debt | 4,063 |
| Payments of insurance premium financing and other short-term debt | 2,738 |
| Dividends paid | 4,864 |
| Net cash provided (used) by financing activities | 16,335 |
| Effect of exchange rate changes on cash | 107 |
| Net increase (decrease) in cash and cash equivalents | 4,730 |
| Cash and cash equivalents at beginning of period | 68,039 |
| Cash and cash equivalents at end of period | 72,769 |
PHIBRO ANIMAL HEALTH CORP (PAHC)
PHIBRO ANIMAL HEALTH CORP (PAHC)